alkenes has been researched along with 1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cesson, V; Chung, KF; Graf, L; Nicod, LP; Obregon, C | 1 |
1 other study(ies) available for alkenes and 1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole
Article | Year |
---|---|
Nitric oxide sustains IL-1β expression in human dendritic cells enhancing their capacity to induce IL-17-producing T-cells.
Topics: Alkenes; Benzoates; Dendritic Cells; Dose-Response Relationship, Drug; Gene Expression Regulation; Humans; Imidazoles; Interleukin-17; Interleukin-1beta; Nitric Oxide; T-Lymphocytes; Time Factors | 2015 |